Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Aus

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
BJU International|July 12, 2001
Selective urological evaluation in men with febrile urinary tract infectionP Ulleryd, B Zackrisson, G Aus, et al.
BJU International|September 1, 1999
Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonographyP Ulleryd, B Zackrisson, G Aus, et al.
Urology|April 1, 1996
Reference range of prostate-specific antigen after transurethral resection of the prostateG Aus, S Bergdahl, R Frösing, et al.
European Urology|July 21, 2001
Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling orderG Aus, S Bergdahl, J Hugosson, et al.
Urology|August 12, 1999
Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomyG Ahlgren, K Pedersen, S Lundberg, et al.
The Prostate|February 19, 2000
Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatmentG Ahlgren, K Pedersen, S Lundberg, et al.
Scandinavian Journal of Urology and Nephrology|February 12, 1998
Diagnosis of prostate cancer: optimal number of prostate biopsies related to serum prostate-specific antigen and findings on digital rectal examinationG Aus, G Ahlgren, J Hugosson, et al.
European Urology|January 1, 1994
Effects of 3 months' neoadjuvant hormonal treatment with a GnRH analogue (triptorelin) prior to radical retropubic prostatectomy on prostate-specific antigen and tumour volume in prostate cancerG Aus, S Brändstedt, M Häggman, et al.
The Journal of Urology|February 25, 1998
Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigenP Lodding, G Aus, S Bergdahl, et al.
BJU International|June 10, 2000
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in SwedenJ Hugosson, G Aus, C Becker, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
BJU International|July 12, 2001
Selective urological evaluation in men with febrile urinary tract infectionP Ulleryd, B Zackrisson, G Aus, et al.
BJU International|September 1, 1999
Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonographyP Ulleryd, B Zackrisson, G Aus, et al.
Urology|April 1, 1996
Reference range of prostate-specific antigen after transurethral resection of the prostateG Aus, S Bergdahl, R Frösing, et al.
European Urology|July 21, 2001
Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling orderG Aus, S Bergdahl, J Hugosson, et al.
Urology|August 12, 1999
Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomyG Ahlgren, K Pedersen, S Lundberg, et al.
The Prostate|February 19, 2000
Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatmentG Ahlgren, K Pedersen, S Lundberg, et al.
Scandinavian Journal of Urology and Nephrology|February 12, 1998
Diagnosis of prostate cancer: optimal number of prostate biopsies related to serum prostate-specific antigen and findings on digital rectal examinationG Aus, G Ahlgren, J Hugosson, et al.
European Urology|January 1, 1994
Effects of 3 months' neoadjuvant hormonal treatment with a GnRH analogue (triptorelin) prior to radical retropubic prostatectomy on prostate-specific antigen and tumour volume in prostate cancerG Aus, S Brändstedt, M Häggman, et al.
The Journal of Urology|February 25, 1998
Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigenP Lodding, G Aus, S Bergdahl, et al.
BJU International|June 10, 2000
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in SwedenJ Hugosson, G Aus, C Becker, et al.
Pageof 5